Compare Multi Medika Internasional Tbk. (MMIX) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multi Medika Internasional Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Multi Medika Internasional Tbk. trades at Rp850 (market cap 4.01T, 54.76M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Multi Medika Internasional Tbk. is far larger — about 38.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MMIX | SCPI | |
|---|---|---|
Market Cap | 4.01T | 104.4B |
Volume | 54.76M | — |
Lot | 547.61K | — |
Turnover | 45.99B | — |
Average Price | 839.86 | — |
Value | 45.99B | — |
Indicative Equilibrium Price | 850 | — |
Indicative Equilibrium Volume | 3.37K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multi Medika Internasional Tbk.
PT Multi Medika Internasional Tbk (the Entity) was established based on the Notarial Deed of Ilmiawan Dekrit S., S.H., M.H., No. 23, dated September 28, 2020. The Entity commenced its commercial operations in 2020.
Read more on MMIX →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
